Michaelson Jennifer's Form 4 filing
Cullinan Therapeutics, Inc. (CGEM) · filed Feb 25, 2026
- Accession no.
- 0001193125-26-072002
- Filed
- Feb 25, 2026
- Trade date
- Feb 23-24, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $76.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Michaelson JenniferCIK 0001838061 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Common Stock | SSaleDisposed | −1,752 | $13.99 | −$24,510.48 | 180,225 | Direct | |
| Feb 24, 2026 | Common Stock | SSaleDisposed | −3,601 | $14.47 | −$52,106.47 | 176,624 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.